High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/150394EB.svg?ark=w1%2F20260515%2F150394EB)](https://nobleid.org/work/w1/20260515/150394EB)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors